New ratio may help doctors understand Men's urinary problems
NCT ID NCT07055425
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will check if a new measure, the Qmax/eGFR ratio, is linked to how severe urinary symptoms are in men over 40. Qmax measures urine flow speed, and eGFR reflects kidney function. One hundred men with urinary issues will take a urine flow test, a blood test, and a symptom questionnaire. The goal is to see if this ratio can help doctors better understand the connection between kidney and urinary health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could give doctors a simple tool to better understand how kidney and urinary function are linked in men with urinary symptoms.
What could go wrong
This is an early observational study with only 100 participants, so results may not apply to all men. It looks for a link, not a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOWER URINARY TRACT SYMPTOM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••